Success Metrics

Active Trials

4(67%)

Phase Distribution

Ph phase_4

17%

Ph not_applicable

67%

Ph phase_3

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 3Large-scale testing

1(16.7%)

Phase 4Post-market surveillance

1(16.7%)

N/ANon-phased studies

4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Terminated(1)

Other(1)

Detailed Status

Recruiting3

Active, not recruiting1

unknown1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 4

Trials by Phase

Phase 31 (16.7%)

Phase 41 (16.7%)

N/A4 (66.7%)

Trials by Status

active_not_recruiting117%

recruiting350%

unknown117%

withdrawn117%

Recent Activity

4 active trials

Showing 5 of 6

recruitingnot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT04603898Not Applicable

Oxalate Formation From Ascorbic Acid

Recruiting

NCT07225764Phase 4

CaOx Stone Prevention

Recruiting

NCT04605055Not Applicable

The Interplay Between Oxalate, Immunity and Infection

Withdrawn

NCT04051346Not Applicable

Dietary Oxalate and Innate Immunity in Kidney Stone Disease

Active Not Recruiting

NCT05417568Not Applicable

Oxalate-Driven Host Responses in Kidney Stone Disease

Recruiting

NCT02393911Phase 3

Dysbiosis in Localized Provoked Vulvodynia (LPV)

Unknown

All 6 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 6